Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Aug 3;10(8):1014.
doi: 10.3390/nu10081014.

Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response

Affiliations
Free PMC article
Randomized Controlled Trial

Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response

Beata Ryszewska-Pokraśniewicz et al. Nutrients. .
Free PMC article

Abstract

Animal studies using tests and models have demonstrated that magnesium exerts an antidepressant effect. The literature contains few studies in humans involving attempts to augment antidepressant therapy with magnesium ions. The purpose of our study was to assess the efficacy and safety of antidepressant treatment, in combination with magnesium ions. A total of 37 participants with recurrent depressive disorder who developed a depressive episode were included in this study. As part of this double-blind study, treatment with the antidepressant fluoxetine was accompanied with either magnesium ions (120 mg/day as magnesium aspartate) or placebo. During an 8-week treatment period, each patient was monitored for any clinical abnormalities. Moreover, serum fluoxetine and magnesium levels were measured, and pharmaco-electroencephalography was performed. The fluoxetine + magnesium and fluoxetine + placebo groups showed no significant differences in either Hamilton Depression Rating Scale (HDRS) scores or serum magnesium levels at any stage of treatment. Multivariate statistical analysis of the whole investigated group showed that the following parameters increased the odds of effective treatment: lower baseline HDRS scores, female gender, smoking, and treatment augmentation with magnesium. The parameters that increased the odds of remission were lower baseline HDRS scores, shorter history of disease, the presence of antidepressant-induced changes in the pharmaco-EEG profile at 6 h after treatment, and the fact of receiving treatment augmented with magnesium ions. The limitation of this study is a small sample size.

Keywords: efficacy; magnesium; pharmaco-electroencephalography; remission; unipolar depression.

Conflict of interest statement

All authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Hamilton Depression Rating Scale (HDRS) scores over time—the measured data and trend.
Figure 2
Figure 2
Serum magnesium levels over time—the measured data and trend.
Figure 3
Figure 3
Odds ratio values for remission.
Figure 4
Figure 4
Odds ratio values for treatment efficacy.

Similar articles

See all similar articles

Cited by 1 article

References

    1. World Health Organization. [(accessed on 15 May 2018)]; Available online: http://www.who.int/en/news-room/fact-sheets/detail/depression.
    1. Deutschenbaur L., Beck J., Kiyhankhadiv A., Mühlhauser M., Borgwardt S., Walter M., Hasler G., Sollberger D., Lang U.E. Role of calcium, glutamate and NMDA in major depression and therapeutic application. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2016;64:325–333. doi: 10.1016/j.pnpbp.2015.02.015. - DOI - PubMed
    1. Poleszak E., Wlaź P., Socała K., Wrobel A., Szewczyk B., Kasperek R., Nowak G. Interaction of glycine/NMDA receptor ligands and antidepressant drugs in the forced swim test. Pharmacol. Rep. 2010;62:58. doi: 10.1016/S1734-1140(10)71161-0. - DOI
    1. Nowak G., Papp M., Paul I.A. The NMDA receptor complex and the action of antidepressant drugs in the CMS model of depression. Eur. J. Pharm. Sci. 1996;4:S53. doi: 10.1016/S0928-0987(97)86204-5. - DOI
    1. Wlaź P., Kasperek R., Wlaź A., Szumiło M., Wróbel A., Nowak G., Poleszak E. NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice. Pharmacol. Rep. 2011;63:1526–1532. - PubMed

Publication types

MeSH terms

Feedback